Extract Antibody-dependent cell-mediated cytotoxicity (ADCMC) was measured in a jlCr-release assay with antibody-sensitized human red blood cells (RBC) as target cells and nonimmune isologous or autologous mononuclear peripheral blood leukocytes (MPBL) as effector cells. ADCMC was readily demonstrable within 6 hr and was independent of exogenous complement (C'). The specificity of the ADCMC reaction was determined by the antiserum employed. Anti-A, anti-B, anti-D, and anti-c sera were all active in ADCMC; the specific lysis was between 35 and 50% with antiserum dilution of 1/1,000, using lo3 target cells and lo6 MPBL. Anti-C, anti-E, and anti-e sera had no detectable activity. Sephadex column separation suggested that this activity was by antibodies of the IgG class.
Cord RBC from infants with RhD fetal-maternal incompatibility were lysed by autologous or isologous MPBL in the absence of exogenous antiserum. ADCMC was between 22% and 42% iwcases with high direct Coombs' test, but was negative with low direct Coombs' test as in five cases of ABO incompatibility.
Speculation
In hemolytic disease of the newborn, the precise mechanisms involved in the destruction of fetal erythrocytes sensitized with maternal antibodies are not well known. The experiments described in this report raise the possibility that ADCMC could be operative in vivn The precise events leading to the destruction of fetal erythrocytes in hemolytic disease of the newborn are not known. There is evidence that fetal erythrocytes coated with maternal IgG antibodies can be lysed by cell-mediated mechanisms (3) (4) (5) . In this context, the potential interactions between mononuclear cells, red cells, and IgG in man have been extensively investigated (1, 2, 10-12). Recent results by Holm and his colleagues (7) (8) (9) have demonstrated ADCMC against human RBC pretreated with isologous antisera to blood group antigens, mediated by nonimmune human MPBL. Using erythrocytes as target cells, the effector population for ADCMC among mononuclear cells appears to be monocytes. Antibody-dependent cytotoxic lymphoid cells (K cells) are not efficient killers of human erythrocytes, although they are extremely active against sensitized nucleated target cells (13, 15) .
In this paper we report a study of ADCMC in fetal-maternal incompatibilities.
MATERIALS A N D METHODS

MEDIUM
The medium used throughout this study was Dulbecco's modified Eagle's medium (16) supplemented with 5% heat-inactivated (56" for 45 min) fetal calf serum, penicillin, streptomycin, and bicarbonate as buffer. When RBC from cord blood were used as target cells, they were washed four times with 0.9 M NaCl at 37" and then once in Hanks' solution before labeling with jlCr.
Antisera to R h System. Both maternal and commercially available human hyperimmune antisera were used. The commercial preprations included: anti-D serum (DADE (19) catalog no. B 4665, lot D-616 EC and D-625 GW), anti-c serum (DADE (19) catalog no. B 4695), anti-C serum (DADE (19) catalog no. B 4685), anti-e serum (DADE (19) catalog no. B 4716) and anti-E serum (DADE (19) catalog no. B 4705). These antisera had no C'-dependent lytic activity. All antisera were inactivated by heating at 56" for 45 min. Anti-D sera had hemagglutination titers (indirect Coombs' test) of 1:524,288 or more. One lot (D-616 EC) contained 6.3 IU/ml IgG and 12.0 IU/ml IgM, measured by a radial diffusion technique (6, 14) .
Anti-A and Anti-B Sera. Both maternal and commercially available human hyperimmune antisera were used. Commercial preparations came from DADE (19): anti-A serum (catalog no. B 4627-1, lot A-478 XX), anti-B serum (catalog no. B 4627-2, lot B-590 WY). These antisera had C-dependent hemolytic activity for R B C p f the relevant blood group but not after inactivation at 56' for 45 min. The hemagglutination titer of each antiserum was greater than 1:524,288. The following standard experimental conditions were used for ADCMC tests, unless otherwise stated. The effector cells (lo6 in 0.5 ml) were mixed with 51Cr-labeled target cells (lo5 in 0.2 ml) and then the heat-inactivated antiserum to these target cells (0.2 ml of various dilutions) was added. The mixtures were placed in conical plastic tubes, 10 x 64 mm (20), and supplemented with 0. l ml medium to a total volume of 1 ml. Controls without added antiserum were included in all experiments. All assays were carried out in duplicate. The reaction mixtures were incubated for 20 hr. After incubation, 1 ml cold phosphate-buffered saline was added, tubes were centrifuged at 365 x g for 1 min, and 1 ml supernatant was carefully removed. Then the radioactivity of the supernatant was counted in a well type y counter (21). The results were expressed as percentage of specific lysis as calculated by the following formula Experimental "Cr release -spontaneous "'Cr release %Specific lysis = x 100
Maximal 51Cr release -spontaneous "'Cr release
Maximal jlCr release was determined by acetic acid lysis of target cells. Spontaneous 51Cr release was 4% or less in all experiments. Cytotoxicity results are expressed as means of duplicates, within which variations rarely exceeded &2.5%.
ANTIBODY-DEPENDENT C'-MEDIATED LYSlS
Fresh, noninactivated immune maternal antiserum at various dilutions was added (0.2 ml) to appropriate jlCr-labeled A, B, or RhD RBC (0.2 ml containing lo5 cells) in conical plastic tubes, and the mixtures were made up to 1 ml with medium. After 20 hr of incubation C'-mediated lysis was assessed in the manner described above.
RESULTS
SPECIFICITY O F ADCMC T O RhD AND A AND B ANTIGENS
In order to investigate specificity, ADCMC experiments were performed using the commercial preparations of human hyperimmune anti-A, anti-B, and anti-D sera. When lo5 0 RhD RBC as target cells were mixed with appropriate concentrations of heatinactivated anti-D serum and with lo6 MPBL as effector cells, lysis was readily demonstrable after 20 hr of incubation (Fig. IA) . This lysis was specific for RhD cells, since Rh-RBC were not lysed under comparable conditions. The absence of lysis of Rh-cells was not due to a technical failure, since A Rh-RBC were lysed in the presence of anti-A serum (Fig. 1 B) .
When heat-inactivated anti-A and anti-B sera were compared for their ability to induce ADCMC of human RBC of different blood group types, lysis was observed only when the labeled RBC carried the appropriate antigens (Fig. IB) .
These experiments, all of which were repeated several times using the same antiserum, demonstrated that the specificity of ADCMC was determined by the specificity of the antiserum. 
ADCMC INDUCED BY ANTIBODIES T O OTHER Rh ANTIGENS
Various labeled RBC were incubated with MPBL and a 1/1,000 dilution of commercial anti-c, anti-C, anti-D, anti-e, and anti-E sera (Table 1) . Definite lysis of homozygous Rh-cc RBC was achieved using the anti-c serum, whereas heterozygous RhDCc (Fig. 2) .
Similar levels of lysis (15-397'0) were observed in nine other experiments.
Almost 90% of the final specific lysis was achieved in the first 6 hr of incubation (Fig. 3) . ADCMC was inhibited in the presence of high concentrations of anti-D serum (see examples in Fig. 1 A and Fig. 4 ). This inhibition may be due to immunoglobulin aggregates in the antiserum. When target cells were incubated for 30 min with anti-D serum and washed twice before the addition of the effecor cells, more lysis was observed (Fig. 4) . Increased lysis was also observed when an aliquot of the anti-D serum was ultracentrifuged before use (Fig.  4) . I Heat-inactivated maternal immune sera on adult red blood cells under standard experimental conditions. The antiserum dilution at which maximal lysis occurred is indicated in parentheses.
Commerical anti-D serum was separated on a Sephadex G-200 column into IgG and IgM fractions. No lysis was seen with the IgM fraction under standard experimental conditions. The IgG fraction did induce lysis, but less strongly than whole serum (Table 2) .
ADCMC AND C'-MEDIATED LYSlS BY MATERNAL I M M U N E SERA ADCMC was induced by 10 sera from mothers with RhD isoimmunization and in all instances was similar to that induced by commercial anti-D sera (Table 3) . Maternal sera from three cases of OA and from two cases of OB isoimmunizations also induced ADCMC (Table 3) . No correlation was found between the titer in the indirect Coombs' test and the percentage of lysis in ADCMC.
Direct (C1-mediated)lysis was observed when Aor B group RBC were incubated for 20 hr with maternal noninactivated immune anti-A or anti-B serum at dilutions of 1/10 or 1/100. On the other hand, no hemolysis of RhD RBC occurred with maternal noninactivated immune anti-D serum. In all controls using heat-inactivated maternal anti-A, anti-B, and anti-D sera no direct lysis occurred. Usually, ADCMC was detectable using heat-inactivated serum at one or two doubling dilutions beyond the C'-mediated hemolytic concentrations for noninactivated serum (Table 4) .
ADCMC O F NEWBORN RBC SENSITIZED IN VlVO
Cord RBC were collected from infants with fetal-maternal blood group incompatibilities. After washing, the cells were labeled and used as target cells. It was found that cells from RhD incompatibility were often lysed by MPBL from normal donors without addition of any further immune serum (Table 5 , Direct ADCMC). From Table 5 it can also be seen that there was some correlation between the degree of lysis observed by direct ADCMC and the titer obtained in the direct Coombs' test. The two cases with the lowest Coombs' titers did not show lysis by the direct ADCMC technique. As a group the children who required two exchange transfusions had a higher percentage of lysis than the others.
No direct ADCMC was observed in the five cases of ABO incompatibilities. Their direct Coombs' titers were between 1/16 and 1/64.
Nevertheless, in all instances the heat-inactivated maternal sera induced ADCMC of the corresponding newborn target RBC, the amount of lysis (data not shown) being similar to that on adult RBC (Table 3 ).
AUTOLOGOUS MONOCYTES FROM NEWBORNS A S EFFECTOR CELLS IN ADCMC
RhD-sensitized cord blood RBC from case 4, with direct Coombs' titer of 114096, were lysed by autologous MPBL used at three concentrations. Comparable lysis was obtained with unrelated donor's MPBL (Fig. 5) . Three other ADCMC tests, in which autologous and isologous effect cells were compared, are shown in Table 5 . 
' D a t a given for autologous effector cells only ' M P B L t o target cell ratio.
' Differential white cell count; 15-20% monocyte content.
Wifferential white cell count; 2-3% monocyte content. Monocytes were removed from a newborn MPBL suspension (case 8 of RhD fetal-maternal incompatibility) by the carbonyl iron technique (13) . ADCMC activity against cord blood RBC (sensitized in vivo) was strongly reduced by this procedure,
DISCUSSION
Our results show that nonimmune MPBL specifically lyse 51Cr-labeled human erythrocytes sensitized in vitro or in vivo with antibodies directed against blood group antigens. In addition to ABO and RhD specificities, an antiserum against the rhesus phenotype cc also induced lysis of RBC of this phenotype. However, antisera to Cc, CC, ee, and EE induced little or no lysis of target cells bearing these antigens.
Isologous and autologous monocytes were found to act as effector cells for both in vitro and in vivo sensitized RBC. After separation of a commercial anti-D serum on a Sephadex column, only the IgG fraction was found to have appreciable ADCMC activity, in agreement with other studies (8) . In all cases specificity of lysis corresponded to the specificity of the isoantiserum employed.
Most release of 51Cr occurred during the first few hours of incubation with MPBL. Assessment of lysis at various MPBL to target cell ratios further suggested that the effector cells were quite efficient, since appreciable jlCr release was detected at ratios of about 1:l. In the absence of granulocytes, monocytes are the effector cells in this system (Table 6) (8, 9, 13) . It is possible that actual effector to target cell ratios are of the order of 0.1-0.2: 1. Our studies do not, however, exclude the possibility that granulocytes may also kill sensitized human erythrocytes (13, 15) .
We also studied ADCMC in cases of fetal-maternal incompatibility. The mechanism of hemolysis in this situation is still unclear. In OA and OB incompatibility, antibodies are found which can induce C'-mediated lysis. The antibodies of Rh incompatibility, however, do not induce this lysis mechanism in vitro. Thus cell-mediated mechanisms may be more important in Rh hemolytic disease (1 -4, l I).
The following observations are compatible with the possibility that ADCMC could operate in vivo. Antibody-dependent monocyte-mediated cytotoxicity can destroy fetal erythrocytes. All of the components necessary for this destruction are present in newborn infants with fetal-maternal incompatibility.
